Thermo Fisher Scientific - TMO Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
News Sentiment
About
FAQ

Consensus Rating: Moderate Buy
Consensus Price Target: $602.81
Forecasted Upside: 5.28%
Number of Analysts: 16
Breakdown:
0 Sell Ratings
5 Hold Ratings
11 Buy Ratings
0 Strong Buy Ratings

^$572.57 As of 04/25/2024 02:09 PM ET

▼ -4.82 (-0.83%)

1 month | 3 months | 12 months

Get New Thermo Fisher Scientific Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for TMO and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for TMO

^$602.81

▲ +5.28% Upside Potential

This price target is based on 16 analysts offering 12 month price targets for Thermo Fisher Scientific in the last 3 months. The average price target is $602.81, with a high forecast of $660.00 and a low forecast of $475.00. The average price target represents a 5.28% upside from the last price of $572.57.

Current Consensus is Moderate Buy

The current consensus among 16 contributing investment analysts is to moderate buy stock in Thermo Fisher Scientific. This Moderate Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
11 buy ratings
5 hold ratings
0 sell ratings

Ratings as of

11/1/2022

0 strong buy ratings
11 buy ratings
5 hold ratings
0 sell ratings

Ratings as of

1/30/2023

0 strong buy ratings
11 buy ratings
5 hold ratings
0 sell ratings

Ratings as of

4/30/2023

0 strong buy ratings
11 buy ratings
5 hold ratings
0 sell ratings

Ratings as of

7/29/2023

0 strong buy ratings
11 buy ratings
5 hold ratings
0 sell ratings

Ratings as of

10/27/2023

0 strong buy ratings
11 buy ratings
5 hold ratings
0 sell ratings

Ratings as of

1/25/2024

0 strong buy ratings
11 buy ratings
5 hold ratings
0 sell ratings

Ratings as of

3/25/2024

0 strong buy ratings
11 buy ratings
5 hold ratings
0 sell ratings

Ratings as of

4/24/2024

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
4/25/2024	JPMorgan Chase & Co.	Boost Target	Overweight ➝ Overweight	$600.00 ➝ $650.00	Low
4/25/2024	Robert W. Baird	Lower Target	Outperform ➝ Outperform	$621.00 ➝ $620.00	Low
4/17/2024	HSBC	Boost Target	Buy ➝ Buy	$630.00 ➝ $660.00	N/A
4/10/2024	The Goldman Sachs Group	Boost Target	Buy ➝ Buy	$550.00 ➝ $640.00	Low
4/4/2024	Evercore ISI	Boost Target	Outperform ➝ Outperform	$575.00 ➝ $610.00	Low
3/18/2024	Citigroup	Initiated Coverage	Neutral	$620.00	Low
2/1/2024	Royal Bank of Canada	Boost Target	Outperform ➝ Outperform	$592.00 ➝ $642.00	Low
2/1/2024	Raymond James	Boost Target	Outperform ➝ Outperform	$515.00 ➝ $605.00	Low
1/24/2024	Barclays	Downgrade	Overweight ➝ Equal Weight	$475.00 ➝ $555.00	Low
1/8/2024	Sanford C. Bernstein	Reiterated Rating	Outperform ➝ Market Perform		Low
12/18/2023	HSBC	Initiated Coverage	Buy	$610.00	Low
12/14/2023	Robert W. Baird	Reiterated Rating	Outperform ➝ Outperform	$670.00	Low
12/13/2023	Wolfe Research	Initiated Coverage	Outperform	$575.00	Low
12/11/2023	Citigroup	Boost Target	Buy ➝ Buy	$530.00 ➝ $575.00	Low
10/26/2023	Stifel Nicolaus	Lower Target	Buy ➝ Buy	$660.00 ➝ $530.00	Low
10/26/2023	Royal Bank of Canada	Lower Target	Outperform ➝ Outperform	$657.00 ➝ $579.00	Low
10/26/2023	Citigroup	Lower Target	Buy ➝ Buy	$625.00 ➝ $530.00	Low
10/26/2023	Raymond James	Lower Target	Outperform ➝ Outperform	$580.00 ➝ $515.00	Low
10/26/2023	KeyCorp	Downgrade	Overweight ➝ Sector Weight		Low
10/25/2023	Wells Fargo & Company	Upgrade	Underweight ➝ Equal Weight	$475.00	Low
10/24/2023	Morgan Stanley	Lower Target	Overweight ➝ Overweight	$640.00 ➝ $600.00	Low
10/18/2023	Raymond James	Lower Target	Outperform ➝ Outperform	$630.00 ➝ $580.00	Low
10/17/2023	JPMorgan Chase & Co.	Lower Target	Overweight ➝ Overweight	$670.00 ➝ $630.00	Low
10/2/2023	Citigroup	Reiterated Rating	Buy ➝ Buy	$625.00	Low
9/29/2023	Barclays	Lower Target		$625.00 ➝ $585.00	Low
9/28/2023	Sanford C. Bernstein	Initiated Coverage	Outperform	$603.00	Low
9/6/2023	Citigroup	Initiated Coverage	Buy ➝ Buy	$625.00	Low
7/28/2023	Wells Fargo & Company	Boost Target	Underweight	$505.00 ➝ $520.00	Low
7/28/2023	Raymond James	Boost Target	Outperform	$595.00 ➝ $630.00	Low
7/27/2023	Royal Bank of Canada	Boost Target		$662.00 ➝ $698.00	Low
7/27/2023	JPMorgan Chase & Co.	Boost Target		$660.00 ➝ $670.00	Low
7/27/2023	Robert W. Baird	Lower Target	Outperform	$664.00 ➝ $625.00	Low
7/27/2023	Barclays	Boost Target	Overweight	$590.00 ➝ $625.00	Low
7/19/2023	Robert W. Baird	Lower Target	Outperform	$670.00 ➝ $664.00	Low
7/18/2023	Raymond James	Initiated Coverage	Outperform	$595.00	Low
7/13/2023	Credit Suisse Group	Upgrade	Neutral ➝ Outperform	$620.00	Low
6/27/2023	Barclays	Lower Target		$610.00 ➝ $590.00	Low
5/25/2023	KeyCorp	Lower Target		$710.00 ➝ $640.00	Low
5/25/2023	JPMorgan Chase & Co.	Lower Target		$675.00 ➝ $660.00	Low
4/27/2023	Citigroup	Lower Target		$700.00 ➝ $650.00	Low
4/27/2023	Morgan Stanley	Lower Target		$670.00 ➝ $620.00	Low
4/27/2023	Robert W. Baird	Lower Target		$693.00 ➝ $670.00	Low
4/27/2023	Barclays	Lower Target		$625.00 ➝ $610.00	Low
4/4/2023	Evercore ISI	Lower Target	Outperform	$615.00 ➝ $610.00	Low
4/4/2023	Barclays	Lower Target	Overweight	$660.00 ➝ $625.00	Low
2/2/2023	SVB Leerink	Boost Target	Outperform	$620.00 ➝ $630.00	Low
2/2/2023	Morgan Stanley	Boost Target	Overweight	$613.00 ➝ $670.00	Low
2/2/2023	Cowen	Boost Target	Outperform	$690.00 ➝ $711.00	Low
2/2/2023	Robert W. Baird	Lower Target		$710.00 ➝ $693.00	Low
2/2/2023	Barclays	Boost Target	Overweight	$630.00 ➝ $660.00	Low
2/2/2023	Citigroup	Boost Target	Buy	$650.00 ➝ $700.00	Low
1/24/2023	Barclays	Boost Target	Overweight	$570.00 ➝ $630.00	Low
1/6/2023	SVB Leerink	Boost Target	Outperform	$555.00 ➝ $620.00	Low
1/3/2023	Wells Fargo & Company	Lower Target	Underweight	$525.00 ➝ $505.00	Low
12/13/2022	Deutsche Bank Aktiengesellschaft	Initiated Coverage	Buy	$620.00	Low
12/6/2022	Royal Bank of Canada	Initiated Coverage	Outperform	$661.00	Low
11/29/2022	Barclays	Lower Target	Overweight	$575.00 ➝ $570.00	Low
10/27/2022	Credit Suisse Group	Lower Target		$620.00	Low
10/27/2022	Morgan Stanley	Lower Target	Overweight	$678.00 ➝ $613.00	Low
10/27/2022	Robert W. Baird	Lower Target	Outperform	$711.00 ➝ $696.00	Low
10/27/2022	Citigroup	Lower Target	Buy	$715.00 ➝ $650.00	N/A
10/27/2022	Benchmark	Downgrade	Buy ➝ Hold		N/A
10/27/2022	Barclays	Lower Target	Overweight	$595.00 ➝ $575.00	N/A
10/27/2022	SVB Leerink	Lower Target	Outperform	$590.00 ➝ $555.00	Low
9/12/2022	Barclays	Lower Target	Overweight	$685.00 ➝ $595.00	Low
8/24/2022	Credit Suisse Group	Initiated Coverage	Neutral	$675.00	Low
8/9/2022	Barclays	Boost Target		$685.00	Low
8/1/2022	Barclays	Boost Target	Overweight	$630.00 ➝ $685.00	Low
7/29/2022	Morgan Stanley	Boost Target	Overweight	$670.00 ➝ $678.00	Low
7/29/2022	SVB Leerink	Boost Target	Outperform	$630.00 ➝ $650.00	Low
7/13/2022	Barclays	Lower Target	Overweight	$675.00 ➝ $630.00	N/A
4/25/2022	Wells Fargo & Company	Downgrade	Equal Weight ➝ Underweight	$605.00 ➝ $525.00	Medium
2/3/2022	BTIG Research	Reiterated Rating	Buy	$718.00	Low
2/3/2022	Wells Fargo & Company	Lower Target	Equal Weight	$700.00 ➝ $605.00	Low
1/26/2022	Barclays	Initiated Coverage	Overweight ➝ Overweight	$700.00	Medium
12/14/2021	Wells Fargo & Company	Boost Target	Equal Weight ➝ Equal Weight	$625.00 ➝ $700.00	High
10/28/2021	Morgan Stanley	Initiated Coverage	Overweight		Medium
10/28/2021	Robert W. Baird	Boost Target	Outperform	$635.00 ➝ $657.00	Medium
10/28/2021	Citigroup	Boost Target	Buy	$700.00 ➝ $715.00	Medium
10/28/2021	SVB Leerink	Boost Target	Outperform ➝ Outperform	$675.00 ➝ $685.00	Medium
10/20/2021	Citigroup	Upgrade	Neutral ➝ Buy	$620.00 ➝ $700.00	Medium
10/14/2021	Cowen	Boost Target	Outperform	$655.00 ➝ $696.00	Medium
9/23/2021	The Goldman Sachs Group	Upgrade	Buy ➝ Conviction-Buy		Low
9/23/2021	Cowen	Boost Target	Outperform	$560.00 ➝ $655.00	Low
9/22/2021	Benchmark	Boost Target	Positive ➝ Buy	$580.00 ➝ $650.00	Medium
9/22/2021	BTIG Research	Boost Target	Buy	$610.00 ➝ $700.00	Medium
9/21/2021	UBS Group	Boost Target	Buy	$595.00 ➝ $670.00	Low
9/20/2021	Jefferies Financial Group	Initiated Coverage	Hold	$540.00	High
9/20/2021	SVB Leerink	Boost Target	Outperform	$600.00 ➝ $675.00	Medium
9/20/2021	KeyCorp	Boost Target	Overweight	$555.00 ➝ $710.00	Low
9/20/2021	JPMorgan Chase & Co.	Boost Target	Overweight	$600.00 ➝ $700.00	Low
9/20/2021	Citigroup	Boost Target	Neutral	$535.00 ➝ $620.00	Low
8/4/2021	Argus	Boost Target	Average ➝ Buy	$530.00 ➝ $600.00	Low
7/29/2021	Cowen	Boost Target	Outperform	$525.00 ➝ $560.00	Low
7/29/2021	BTIG Research	Boost Target	Buy	$590.00 ➝ $610.00	Low
7/19/2021	SVB Leerink	Reiterated Rating	Outperform		Low
7/16/2021	Benchmark	Initiated Coverage	Buy	$580.00	Medium
7/12/2021	KeyCorp	Boost Target	Overweight	$520.00 ➝ $555.00	Low
6/23/2021	Robert W. Baird	Boost Target	Positive ➝ Outperform	$545.00 ➝ $550.00	Low
6/15/2021	The Goldman Sachs Group	Lower Target	Buy	$590.00 ➝ $530.00	Low
5/3/2021	Robert W. Baird	Reiterated Rating	Buy		Low
4/16/2021	Evercore ISI	Boost Target	Outperform	$525.00 ➝ $540.00	Low
3/29/2021	UBS Group	Lower Target	Buy	$588.00 ➝ $560.00	Low
3/18/2021	KeyCorp	Upgrade	Sector Weight ➝ Overweight	$520.00	Low
3/8/2021	Barclays	Initiated Coverage	Overweight	$525.00	N/A
3/2/2021	Barclays	Initiated Coverage	Overweight	$525.00	Medium
2/3/2021	BTIG Research	Boost Target	Buy	$540.00 ➝ $590.00	High
2/2/2021	Citigroup	Boost Target	Buy	$500.00 ➝ $530.00	Low
2/2/2021	Stifel Nicolaus	Boost Target	Buy	$530.00 ➝ $600.00	Low
2/2/2021	Cowen	Boost Target	Outperform	$525.00 ➝ $585.00	Low
2/2/2021	Morgan Stanley	Boost Target	Overweight	$535.00 ➝ $575.00	Low
2/2/2021	UBS Group	Boost Target	Positive ➝ Buy	$566.00 ➝ $588.00	Low
2/2/2021	SVB Leerink	Boost Target	Outperform	$525.00 ➝ $560.00	Low
1/12/2021	Credit Suisse Group	Boost Target		$556.00 ➝ $580.00	High
1/8/2021	Credit Suisse Group	Upgrade	Neutral ➝ Outperform	$490.00 ➝ $556.00	Medium
12/16/2020	Smith Barney Citigroup	Downgrade	Buy ➝ Neutral		High
12/2/2020	Credit Suisse Group	Boost Target	Neutral	$488.00 ➝ $490.00	Low
12/2/2020	Robert W. Baird	Boost Target	Outperform	$512.00 ➝ $523.00	Low
12/2/2020	The Goldman Sachs Group	Initiated Coverage	Buy	$570.00	Low
11/9/2020	KeyCorp	Initiated Coverage	Sector Weight ➝ Sector Weight	$550.00	High
10/27/2020	Needham & Company LLC	Boost Target	Buy	$477.00 ➝ $539.00	Low
10/22/2020	BTIG Research	Boost Target	Positive ➝ Buy	$475.00 ➝ $540.00	High
10/22/2020	Robert W. Baird	Boost Target	Outperform	$481.00 ➝ $512.00	High
10/22/2020	Credit Suisse Group	Boost Target	Neutral	$432.00 ➝ $488.00	High
10/22/2020	Morgan Stanley	Boost Target	Overweight	$485.00 ➝ $535.00	High
10/22/2020	SVB Leerink	Boost Target	Outperform	$470.00 ➝ $525.00	High
10/5/2020	JPMorgan Chase & Co.	Boost Target	Overweight	$460.00 ➝ $480.00	High
9/30/2020	Atlantic Securities	Initiated Coverage	Overweight	$494.00	Medium
9/17/2020	Needham & Company LLC	Boost Target	Buy	$468.00 ➝ $477.00	Low
9/14/2020	Morgan Stanley	Initiated Coverage	Overweight	$485.00	Low
9/11/2020	Bank of America	Boost Target	Buy	$460.00 ➝ $480.00	Low
9/11/2020	Credit Suisse Group	Boost Target	Neutral	$425.00 ➝ $432.00	Low
9/11/2020	SVB Leerink	Boost Target	Outperform	$455.00 ➝ $470.00	Medium
9/11/2020	Citigroup	Boost Target	Buy	$471.00 ➝ $485.00	Medium
8/21/2020	Credit Suisse Group	Boost Target	Neutral	$405.00 ➝ $425.00	Medium
8/20/2020	JPMorgan Chase & Co.	Reiterated Rating	Overweight	$460.00	Low
8/13/2020	Needham & Company LLC	Initiated Coverage	Buy	$468.00	Low
7/27/2020	Argus	Boost Target		$370.00 ➝ $450.00	Low
7/23/2020	Robert W. Baird	Boost Target		$352.00 ➝ $436.00	Low
7/23/2020	Needham & Company LLC	Boost Target	Buy	$415.00 ➝ $468.00	Low
7/23/2020	BTIG Research	Boost Target	Buy	$372.00 ➝ $475.00	Low
7/23/2020	Citigroup	Boost Target	Buy	$390.00 ➝ $471.00	Low
7/23/2020	Stifel Nicolaus	Boost Target	Hold ➝ Buy	$370.00 ➝ $460.00	Low
7/23/2020	SVB Leerink	Boost Target	Outperform	$365.00 ➝ $455.00	Low
7/21/2020	UBS Group	Boost Target	Buy	$385.00 ➝ $440.00	High
7/7/2020	Needham & Company LLC	Boost Target	Buy	$383.00 ➝ $415.00	Low
7/6/2020	Cowen	Reiterated Rating	Buy	$380.00	Low
4/23/2020	Citigroup	Boost Target	Buy	$365.00 ➝ $390.00	High
4/23/2020	SVB Leerink	Boost Target	Outperform	$330.00 ➝ $365.00	High
4/23/2020	Needham & Company LLC	Boost Target		$341.00 ➝ $383.00	High
4/22/2020	Needham & Company LLC	Boost Target	Buy	$341.00 ➝ $383.00	Medium
4/21/2020	Wells Fargo & Company	Boost Target	Equal Weight	$300.00 ➝ $340.00	High
4/2/2020	Stifel Nicolaus	Lower Target	Buy	$345.00 ➝ $315.00	Medium
3/30/2020	Wells Fargo & Company	Lower Target	Equal Weight	$345.00 ➝ $300.00	Medium
3/20/2020	Citigroup	Lower Target	Buy	$390.00 ➝ $365.00	Low
3/4/2020	Robert W. Baird	Boost Target	Outperform	$340.00 ➝ $341.00	High
2/24/2020	Argus	Reiterated Rating	Buy ➝ Positive	$370.00	High
1/31/2020	BTIG Research	Boost Target	Buy ➝ In-Line	$342.00 ➝ $372.00	High
1/31/2020	Robert W. Baird	Boost Target	Outperform	$319.00 ➝ $340.00	High
1/31/2020	Wells Fargo & Company	Lower Target	Equal Weight	$350.00 ➝ $345.00	High
1/31/2020	Needham & Company LLC	Boost Target	Buy	$331.00 ➝ $341.00	High
1/31/2020	Citigroup	Boost Target	Buy	$380.00 ➝ $390.00	High
1/22/2020	Credit Suisse Group	Initiated Coverage	Neutral	$341.00	Low
1/7/2020	Wells Fargo & Company	Initiated Coverage	Equal Weight	$350.00	Low
1/6/2020	Citigroup	Initiated Coverage	Buy	$380.00	Low
1/6/2020	Cowen	Reiterated Rating	Outperform	$330.00 ➝ $365.00	Medium
1/3/2020	Needham & Company LLC	Initiated Coverage	Strong-Buy	$271.00	Medium
11/14/2019	Stifel Nicolaus	Initiated Coverage	Buy	$345.00	Medium
11/14/2019	Evercore ISI	Upgrade	Outperform		High
10/24/2019	Robert W. Baird	Boost Target	Outperform	$305.00 ➝ $319.00	Low
10/23/2019	JPMorgan Chase & Co.	Boost Target	Overweight	$315.00 ➝ $330.00	Low
7/31/2019	Credit Suisse Group	Reiterated Rating	Buy	$310.00	Low
7/25/2019	Needham & Company LLC	Boost Target	Buy ➝ Buy	$315.00 ➝ $321.00	Low
7/16/2019	Needham & Company LLC	Downgrade	Strong-Buy ➝ Buy	$315.00	Low
7/15/2019	Barclays	Set Target	Buy	$330.00	Medium
5/30/2019	Wolfe Research	Initiated Coverage	Outperform ➝ Outperform		Low
5/23/2019	Needham & Company LLC	Reiterated Rating	Strong-Buy ➝ Strong-Buy	$313.00 ➝ $315.00	Low
5/23/2019	BTIG Research	Boost Target	Average ➝ Buy	$320.00	Low
5/23/2019	UBS Group	Boost Target	Buy	$305.00 ➝ $320.00	Low
5/1/2019	Argus	Boost Target	Buy ➝ Buy	$285.00 ➝ $310.00	Low

(Data available from 4/25/2019 forward)

News Sentiment Rating

0.85 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

21 very positive mentions
14 positive mentions
2 negative mentions
0 very negative mentions

Mentions as of

9/28/2023

27 very positive mentions
30 positive mentions
8 negative mentions
4 very negative mentions

Mentions as of

10/28/2023

10 very positive mentions
14 positive mentions
2 negative mentions
1 very negative mentions

Mentions as of

11/27/2023

34 very positive mentions
15 positive mentions
1 negative mentions
1 very negative mentions

Mentions as of

12/27/2023

38 very positive mentions
14 positive mentions
4 negative mentions
2 very negative mentions

Mentions as of

1/26/2024

44 very positive mentions
28 positive mentions
2 negative mentions
1 very negative mentions

Mentions as of

2/25/2024

38 very positive mentions
21 positive mentions
0 negative mentions
1 very negative mentions

Mentions as of

3/26/2024

35 very positive mentions
29 positive mentions
3 negative mentions
0 very negative mentions

Mentions as of

4/25/2024

Current Sentiment

Recent Stories by Sentiment

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Today's Range

Now: $572.57

$569.98

$577.99

50 Day Range

MA: $572.61

$541.78

$599.43

52 Week Range

Now: $572.57

$415.60

$603.82

Volume

609,219 shs

Average Volume

1,555,944 shs

Market Capitalization

$218.56 billion

P/E Ratio

37.06

Dividend Yield

0.27%

Beta

0.8

Frequently Asked Questions

What sell-side analysts currently cover shares of Thermo Fisher Scientific?: The following Wall Street analysts have issued stock ratings on Thermo Fisher Scientific in the last year: Barclays PLC, Citigroup Inc., Credit Suisse Group AG, Evercore ISI, HSBC Holdings plc, JPMorgan Chase & Co., KeyCorp, Morgan Stanley, Raymond James, Robert W. Baird, Royal Bank of Canada, Sanford C. Bernstein, Stifel Nicolaus, StockNews.com, The Goldman Sachs Group, Inc., TheStreet, Wells Fargo & Company, and Wolfe Research.
View the latest analyst ratings for TMO.
What is the current price target for Thermo Fisher Scientific?: 16 Wall Street analysts have set twelve-month price targets for Thermo Fisher Scientific in the last year. Their average twelve-month price target is $601.56, suggesting a possible upside of 4.8%. HSBC Holdings plc has the highest price target set, predicting TMO will reach $660.00 in the next twelve months. Wells Fargo & Company has the lowest price target set, forecasting a price of $475.00 for Thermo Fisher Scientific in the next year.
View the latest price targets for TMO.
What is the current consensus analyst rating for Thermo Fisher Scientific?: Thermo Fisher Scientific currently has 5 hold ratings and 11 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for TMO.
What other companies compete with Thermo Fisher Scientific?: Other companies that are similar to Thermo Fisher Scientific include AstraZeneca, Novartis, Abbott Laboratories, Pfizer and Amgen. Learn More about companies similar to Thermo Fisher Scientific.
How do I contact Thermo Fisher Scientific's investor relations team?: Thermo Fisher Scientific's physical mailing address is 168 Third Avenue, Waltham MA, 02451. The medical research company's listed phone number is (781) 622-1000 and its investor relations email address is [email protected]. The official website for Thermo Fisher Scientific is www.thermofisher.com. Learn More about contacing Thermo Fisher Scientific investor relations.

Thermo Fisher Scientific - TMO Stock Price Target and Predictions

Analyst Price Target for TMO

Current Consensus is Moderate Buy

Past Monthly Recommendations

Latest Recommendations

News Sentiment Rating

0.85 (Buy)

News Sentiment Over Time

Current Sentiment

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Frequently Asked Questions

What sell-side analysts currently cover shares of Thermo Fisher Scientific?

What is the current price target for Thermo Fisher Scientific?

What is the current consensus analyst rating for Thermo Fisher Scientific?

What other companies compete with Thermo Fisher Scientific?

How do I contact Thermo Fisher Scientific's investor relations team?